Sean Bagshaw

Biography

Dr Bagshaw is a Clinician Scientist and Associate Professor of Critical Care Medicine. He is currently serving as Interim Chair of the Department.  He acquired training at the University of Calgary (Internal Medicine, Critical Care Medicine, and Masters of Science Epidemiology) prior to completing a Critical Care Nephrology fellowship in the Department of Intensive Care Medicine, at the Austin Hospital in Melbourne, Australia. Dr Bagshaw is supported by a Canada Research Chair in Critical Care Nephrology and a Clinical Investigator Award from Alberta Innovates – Health Solutions. Dr Bagshaw’s main research interests have focused on the clinical, epidemiological, translational, and health services delivery issues related to acute kidney injury and extracorporeal blood purification in critically ill patients. Dr Bagshaw’s research also focuses ICU organization, capacity and rapid response systems, frailty in critical illness, and technological support for critically ill older patients. His research is supported from grants from the Canadian Institutes for Health Research, Alberta Innovates – Health Solutions, the MSI Foundation, the University Hospital Foundation, the Canadian Intensive Care Society, and the Technology Evaluation in the Elderly Network. He has published over 100 peer-reviewed papers, numerous book chapters, and peer-reviewed for over 20 medical journals. Dr Bagshaw is a member of several organizations including the Canadian Critical Care Society, Canadian Critical Care Trials Group, Australia New Zealand Intensive Care Society, and the Acute Kidney Injury Network, and the Acute Dialysis Quality Initiative

Research Interest

acute kidney injury, acute lung injury, acute respiratory distress, ARDS, bloodstream infection, burnout, cardiac surgery, chronic respiratory failure, comorbidity, cost, critically ill, CRRT, dabetes, daibetes, dialysis, disability, distributive shock, duration of antimicrobials, end-of-life care, endotoxin, epidemiology, extracorporeal, fluid balance, frailty, furosemide, H1N1, health care providers, heart failure, hemoglobin, high frequency oscillation, home mechanical ventilation, ICU, ICU discharge, influenza A, interstitial lung disease, ketoacidosis, lung injury, lung transplant, mechancal ventilation, medical emergency team, moral distress, morality, morbidity, mortality, multi-centre, multi-national, observational, older patients, outcomes, pandemic, pediatric, pilot, pleth variability, pulse oximetry, quality, quality of life, rapid response, renal replacement therapy, safety, sepsis, timing, transfusion trigger, trauma